InsiderTrades

Form 4 for TWST Twist Bioscience Corp

Accepted 2021-11-23 00:00:00 ET · period of report 2021-11-19 · accession 0001214659-21-012191 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2021-11-23 2021-11-22 TWST Banyai William See Remarks, Dir S - Sale $101.83 -20.0K 285.4K -7% -$2.03M
2021-11-23 2021-11-19 TWST Banyai William See Remarks, Dir F - Tax $110.62 -967 305.4K -0.3% -$107.0K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-22 S D 300 $96.97 305,111 D — — (F3) Represents the weighted average sales price per share. The shares sold at prices ranging from $96.62 to $97.15 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
2 Common Common Stock 2021-11-19 F D 967 $110.62 305,411 D — — (F1) Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
3 Common Common Stock 2021-11-22 S D 1,601 $98.55 303,510 D — — (F4) Represents the weighted average sales price per share. The shares sold at prices ranging from $98.07 to $98.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
4 Common Common Stock 2021-11-22 S D 1,892 $99.73 301,618 D — — (F5) Represents the weighted average sales price per share. The shares sold at prices ranging from $99.14 to $100.025 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
5 Common Common Stock 2021-11-22 S D 3,966 $100.66 297,652 D — — (F6) Represents the weighted average sales price per share. The shares sold at prices ranging from $100.24 to $101.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
6 Common Common Stock 2021-11-22 S D 3,926 $101.81 293,726 D — — (F7) Represents the weighted average sales price per share. The shares sold at prices ranging from $101.36 to $102.21 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
7 Common Common Stock 2021-11-22 S D 3,900 $102.86 289,826 D — — (F8) Represents the weighted average sales price per share. The shares sold at prices ranging from $102.39 to $103.37 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
8 Common Common Stock 2021-11-22 S D 1,967 $103.78 287,859 D — — (F9) Represents the weighted average sales price per share. The shares sold at prices ranging from $103.40 to $104.37 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
9 Common Common Stock 2021-11-22 S D 2,431 $104.92 285,428 D — — (F10) Represents the weighted average sales price per share. The shares sold at prices ranging from $104.56 to $105.26 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.